Prostate cancer: enzalutamide would increase the life expectancy of patients
In patients with hormone-sensitive metastatic prostate cancer, enzalutamide may increase life expectancy. With 1.6 million cases diagnosed in 2015, prostate ...
Read moreTag: ASCO 2019
ASCO 2019: these different ways of operating on colorectal cancer
The OSLO-COMET trial, presented at the largest world cancer conference (ASCO) in Chicago, studied the different ways of operating on ...
Read more
Breast cancer: a tool to identify patients who can go without chemotherapy
Last year, researchers presented a new tool capable of identifying patients who can go without chemotherapy in the treatment of ...
Read more
ASCO 2019: novelties in the fight against cancer
The congress of the American Society of Clinical Oncology (ASCO) which opened on May 31 in Chicago brings together oncologists ...
Read more
Cancer: metal injected into tumors to boost radiotherapy
Institut Curie caused a sensation at the American Society of Clinical Oncology (ASCO) congress by presenting its work on injections ...
Read more